Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 7, 2021
Event: Entry into a Material Definitive Agreement regarding a private placement financing.
Key Financial Metrics and Transaction Details
- Financing Instrument: Future advance convertible promissory notes (Notes) and Warrants.
- Total Principal Amount: Up to $543,478.
- Initial Disbursement: $250,000 received on September 7, 2021 (additional disbursement under an existing note).
- Interest Rate: 5% per annum.
- Maturity: 12 months from issuance.
- Warrants Issued: 2,777,779 shares.
- Warrant Exercise Price: $0.18 per share.
- Warrant Term: 5 years.
- Conversion Price: $0.18 per share initially; subject to a discount mechanism (90% of closing price or 75% of lowest VWAP) after the Registration Statement becomes effective, with a floor of $0.01.
Material Changes and Agreements
The Company entered into Securities Purchase Agreements with accredited investors on September 3, 2021, closing on September 7, 2021. Key structural changes include:
- Subordination: The rights of the new Purchasers are subordinate to NH Expansion Credit Fund Holdings LP ("North Haven Expansion") pursuant to a Subordination Agreement.
- Collateral: The Company entered into Security Agreements securing obligations under the Notes.
- Registration Rights: The Company agreed to file a Registration Statement within 90 days of the Closing Date to register 100% of shares issuable upon conversion of Notes and exercise of Warrants.
Guidance, Risks, and Contingencies
- Regulatory Compliance: Securities were sold under Section 4(a)(2) of the Securities Act as an exemption from registration.
- Covenants: Notes contain customary events of default and covenants, including limitations on incurring additional indebtedness and liens.
- Future Obligations: The Company is obligated to maintain the Registration Statement continuously effective until all Registrable Securities are sold or eligible for unrestricted sale under Rule 144.
Investor Verification Checklist
- Verify the total amount of capital actually advanced under the $543,478 aggregate principal limit.
- Review the full text of the Subordination Agreement (Exhibit 10.2) to understand the priority of claims relative to North Haven Expansion.
- Confirm the timeline for the filing and effectiveness of the Registration Statement (due within 90 days of September 7, 2021).
- Assess the dilution impact of the 2,777,779 warrants and potential note conversions at the $0.18 price point or discounted VWAP.
- Check for any subsequent filings regarding the "future advance" disbursements to determine if the full $543,478 was utilized.